ADALIMUMAB-RYVK for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 23 adverse event reports in the FDA FAERS database where ADALIMUMAB-RYVK was used for Psoriasis.
Most Reported Side Effects for ADALIMUMAB-RYVK
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 70 | 15.1% | 7 | 10 |
| Product dose omission issue | 67 | 14.5% | 3 | 13 |
| Crohn's disease | 65 | 14.0% | 0 | 7 |
| Inappropriate schedule of product administration | 57 | 12.3% | 8 | 19 |
| Rheumatoid arthritis | 47 | 10.2% | 2 | 9 |
| Death | 45 | 9.7% | 44 | 12 |
| Diarrhoea | 43 | 9.3% | 2 | 13 |
| Arthralgia | 42 | 9.1% | 1 | 7 |
| Pain | 42 | 9.1% | 1 | 11 |
| Fatigue | 39 | 8.4% | 0 | 9 |
| Drug ineffective | 38 | 8.2% | 2 | 12 |
| Abdominal pain | 37 | 8.0% | 0 | 7 |
| Malaise | 31 | 6.7% | 4 | 4 |
| Headache | 26 | 5.6% | 0 | 5 |
| Product dispensing issue | 24 | 5.2% | 0 | 5 |
Other Indications for ADALIMUMAB-RYVK
Crohn's disease (133)
Rheumatoid arthritis (107)
Ankylosing spondylitis (43)
Colitis ulcerative (40)
Hidradenitis (34)
Psoriatic arthropathy (33)
Product used for unknown indication (30)
Uveitis (8)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)